TRIAL MANAGEMENT
Clinical Trials And TMF 101 Learning Series: 2nd Session
The “Clinical Trials and TMF 101 Learning Series” kicks off it’s second session with three industry experts, that goes through some of the basics of clinical trials.
Clinical Trials And TMF 101 Learning Series: 1st Session
Spark a deeper and broader understanding of the world of Drug Development, Clinical Trials, Regulations, the Trial Master File, and much more – for the industry novice as well as the guru.
Sponsors' Advice On Disclosure As A Service
Representatives from Teva and Lung Biotechnology share their insights for other sponsors considering Disclosure as a Service. Watch the short video now.
Solving The Impossible In Glioblastoma With An AI Synthetic Control Arm
This video discusses Medicenna’s MDNA55-05 clinical trial; a single-arm, open-label, multicenter study that offers a promising opportunity to improve outcomes for recurrent glioblastoma.
Ensuring Completeness, Accuracy, And Consistency From Source To Archive
Discover how proficient TMF handling can proactively address potential pitfalls, fostering a state of preparedness for regulatory evaluations.
CTIS Master Series 1: Are You Ready For CTIS?
In this informative webinar, clinical trial disclosure experts Francine Lane and Thomas Wicks provide a high-level overview of EU CTR/CTIS regulations, show how they differ from the EU CTD directive, share timelines for compliance, and discuss the scope of data sharing.
Navigating Early Phase CNS-Active Drug Development
Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating th...
How RWD Reshapes Patient Recruitment Strategies
Discover how real-world data (RWD) is transforming patient recruitment by shifting from traditional site-centered methods to a patient-first approach.
Defining And Implementing The Right Oncology Digital Strategy
A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.
The New Era Of Project Optimus: Implications For Oncology Development Strategy
In this presentation, expert speakers bring the impact of Project Optimus to life through real-world case studies and practical examples.
Modernizing Clinical Research With Patient-Centric Digital Data Collection
Accelerate clinical trial modernization with streamlined collection of continuous, high-precision data centered on the patient.
Yes, Your Study Is At Risk: Risk Mitigation Plans For Endpoints
Ocular endpoints often introduce unique bottlenecks that can stall enrollment and compromise data integrity. This presentation provides the tools for a streamlined, resilient clinical trial strategy.
Accelerate Your Data With Our Co-Located Clinic And Lab
Watch as we take your fresh sample from our clinic to PBMC separation. This video overviews our optimized workflows that ensure timely processing, transport, and analysis of your samples.
Think U.S.A.: The Operations Behind Your Clinical Trials
Ready to think differently about early-phase clinical development? Check out the spotlight on our U.S. clinical facilities and the incredible teams behind them.
Say It With Technology: How Alnylam Fosters A Connected Relationship With Sites
Alnylam Pharmaceuticals is developing an entirely new class of medicines and delivered the world’s first and only approved RNAi therapeutics in 2018 and 2019. Learn how Alnylam earned its reputation among investigators as a sponsor of choice by standardizing studies...
Strategic Considerations For A Successful CNS Clinical Development Pathway
Dr. Beatrice Setnik, Chief Scientific Officer at Altasciences, discusses tactics for a successful clinical development pathway for CNS-active drugs.
Patient First Solutions For Oncology
Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.
Illuminating IHC: From Biomarker To Clinical Trial Assay
Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.
Keeping Up With ClinOps: Why And How To Improve Delivery
Industry experts discuss the concept of a trial platform as a service and how it can accelerate and enhance the day-to-day functions of clinical operations throughout the entire lifecycle of a study.
Audit Trails: Demonstrating TMF Oversight, Completeness, & Accuracy
Listen in as experts share their knowledge and experience to provide insights on leveraging audit trails for oversight, completeness, and accuracy of TMF management systems.
Exploring The Principles Integral To Rare Disease Drug Development
This on-demand webinar offers valuable insights into successful rare disease drug development, including study design, regulatory engagement, and market access strategy.
CAR-T Cell Therapies: Advancements In Cancer Trials & Treatment
Watch as Managing Editor of Pharmaceutical Technology Jeanne Linke Northrop talks with Tanmay Jain, Sr. Director of Trial Design Solutions within Medidata AI, about the use of CAR-T cell therapies within the oncology space.
Webinar: Reimbursement Methods For Sustainable CGT Business Models
Learn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.
The Path Forward, Altasciences' Approach To Project Management
Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.
Why Disclosure Assessments Are The First Step To Improvement
Whether your organization lacks formal disclosure policies and procedures, or has longstanding SOPs in place, the best way to gauge the effectiveness of your clinical trial disclosure process is via a third-party assessment.
Do Mobile Visits Drive Faster Study Results?
Discover solutions to clinical trial challenges — this on-demand webinar by PCM Trials and Clinical Leader offers insights into the role of mobile nurse visits in overcoming patient dropout and trial delays.
Cognitive, Pharmacodynamic Testing During FIH CNS Trials
A comprehensive review of optimal timing and methodologies for cognitive and pharmacodynamic testing during first-in-human trials on CNS-active compounds.
Clinical Research Without Borders
Explore strategies for navigating global clinical trials with, Afshawn Chakamian of Avidity Biosciences, Dr. Amy Raymond of Worldwide Clinical Trials, Scott Schliebner of Novotech, and Scout’s KimberLee Heidmann.
Why Disclosure As A Service?
Two clinical trial sponsors – one larger pharmaceutical company and one smaller biotech – share with TrialScope what their main reasons were for initially considering Disclosure as a Service. Watch the short video.
Perceptive eClinical
Learn about a randomization and trial supply management (RTSM) solution that helps keep your trial on track.
